SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001609351-17-000129
Filing Date
2017-12-20
Accepted
2017-12-20 17:13:22
Documents
1
Period of Report
2017-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151380798888443.html 4  
1 FORM 4 wf-form4_151380798888443.xml 4 5365
  Complete submission text file 0001609351-17-000129.txt   6779
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address
Marrazzo Jeffrey D (Reporting) CIK: 0001631262 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36819 | Film No.: 171267424